Nay AI is an AI search engine for business scenarios, providing enterprise users with accurate business intelligence, industry reports and market data retrieval capabilities.

NayAI

Core parameters and statistics of Nay AI

Nay AI is positioned as an AI-driven medical and health ecosystem platform, officially described as an "empathy-first elder care platform" that uses artificial intelligence technology to provide personalized and affordable medical and health services for the elderly and pregnant women. The platform has not yet been officially released to the public and is currently in the development and testing stages.

Projects	Public Information
Official positioning	Empathy-first AI platform for elderly care and medical health
Core technology stack	URUS integrated architecture Skimmer natural language understanding engine ML, Computer Vision, NLP, edge computing 5G
Target user group	Elderly group (over 60 years old), pregnant women, medical service providers
Deployment form	Web (nay.ai), mobile application under development
Product status	Not officially released, core components have been developed for more than 2 years
Place of Belonging	India (the founding team comes from IIT Delhi, IIM, Stanford, etc.)
Public content	Healthcare news aggregation, blog, investor page, nursing service introduction

Engineering implications of technical architecture: The URUS integration architecture is responsible for cross-system data integration, and the Skimmer NLU engine handles the understanding and semantic retrieval of medical text. The combination of the two enables the platform to extract structured information from dispersed health data sources. The introduction of edge computing and 5G is aimed at remote monitoring scenarios - the health data of the elderly needs to be initially processed locally and uploaded to the cloud only when necessary to reduce latency and protect privacy.

Product Maturity Boundary: The official website clearly states that "have yet to formally launch the platform" (have yet to formally launch the platform). The currently accessible pages are mainly brand display, team introduction, medical and health news aggregation and investor relations content. This means that the functional features described in this article are based on the official technical vision, and the actual delivery capabilities need to be verified after the official release.

Users and market recognition of Nay AI

Nay AI has not yet officially entered the market. User and market recognition are currently mainly reflected in the industry reputation of the founding team and the preliminary preparations for the project.

Founding team background: The team consists of four core members - serial entrepreneur Avijit (with two previous profitable exits), IIT Delhi computer science professor Subhashis (computer vision expert), Jaslok Hospital senior consultant Sudeshna (MD, FRCOG, robotic surgery expert), IIT-IIM-Stanford alumnus Nitin (professional investor). The team's background spans academic research, clinical care, entrepreneurial operations and capital operations, and has a certain foundation of trust in the field of medical AI.

Project Phase: The predecessor development of the core technology component (URUS integrated architecture Skimmer NLU engine) began in the field of education technology before 2020, and shifted to the medical and health direction after 2020. The official investor page is open, indicating that the project is advancing financing or has received preliminary capital support.

Third Party Recognition: As of now, no public third-party reviews, corporate customer cases or industry award information has been retrieved. The platform has not yet entered the beta testing stage and market validation has not yet started. This is the most important prerequisite when evaluating this tool - Nay AI is currently in the "technical vision-driven" stage rather than the "market validation-driven" stage.

Nay AI’s cost advantage

Since the platform has not been officially released and no pricing information has been disclosed, cost analysis can only be deduced based on its technical architecture and operating model.

C-side/individual users: The platform's goal is to provide "personalized and affordable medical and health services". The official website emphasizes "affordable healthcare to every human being", implying that its pricing strategy may be biased towards the inclusive route. However, the specific charging model for elderly users and pregnant women has not yet been made public. The official pricing page shall prevail.

Developers/Partners: Nay AI’s URUS integration architecture and Skimmer NLU engine have technology reuse potential and may open API access to medical institutions or developers, but as of now, no developer documents or API solutions have been disclosed. This is consistent with the strategy of similar AI medical platforms (such as Babylon Health and Ada Health) that usually open APIs after the product matures.

Corporate/Institutional Cooperation: The investor page on the official website states that the project is open to capital cooperation. B2B cooperation with hospitals, nursing homes, and insurance companies will be the core path for its commercialization. The cost structure of enterprise cooperation usually includes platform licensing fees, integration implementation fees and ongoing operation and maintenance fees. Specific terms are subject to business negotiations.

Hidden cost considerations: For healthcare platforms, the largest hidden costs come from compliance certification (HIPAA, GDPR, etc.), medical liability insurance, and clinical verification investments. These compliance costs often far exceed software development and operation and maintenance expenses, and are the most underestimated expenses for start-up medical AI companies.

Main functions of Nay AI

Nay AI's functional system revolves around the three main lines of "continuous monitoring + AI-assisted decision-making + timely intervention". It is not a single application tool, but an integrated ecosystem for elderly health and maternal care.

• Health risk profiling and prediction: By continuously monitoring the health and lifestyle parameters of the elderly, AI algorithms build personalized health risk maps to identify high-risk groups and provide early warning. Engineering Implications: The accuracy of the risk prediction model is highly dependent on the quality and coverage of the training data. The false positive rate and false negative rate in the initial stage need to be continuously calibrated in real scenarios.
• 24/7 Smart Connection: The platform claims to provide 24/7 smart connection services, allowing the elderly to stay connected with the medical care ecosystem at any time. Implementation path: Edge computing devices process sensor data locally, cloud AI is responsible for complex analysis and decision support, and the two collaborate through the 5G network.
• Age-appropriate health guidance: Based on the user's age, medical history and lifestyle habits, AI generates age-appropriate health suggestions and care plans. Point of differentiation: Different from general health advice, Nay AI emphasizes "age adaptability" and provides customized output based on the coexistence of multiple diseases and medication management needs of the elderly group.
• Clinical Decision Support: Provides medical service providers with intelligent assistance for clinical decision-making in geriatrics, including medication conflict detection, treatment plan recommendation, and prognosis assessment. Prerequisites: This requires deep integration with the HIS/EMR system of the medical institution. The complexity of integration varies from hospital to hospital.
• Remote monitoring and early warning: Combined with wearable devices and home sensors, it can monitor the activity status, vital signs and medication compliance of the elderly in real time, and automatically notify family members or emergency centers when abnormalities occur. Technical Challenge: The sensitivity and specificity of abnormality detection need to be balanced - too sensitive will cause alarm fatigue, and too slow may delay treatment.

Function Matrix Comparison:

Functional Dimension	Elderly Care	Maternal Care
Health monitoring	Activity status, vital signs, medication compliance	Pregnancy indicators, fetal heart rate monitoring, prenatal check-up reminders
AI-assisted decision-making	Clinical decision support for geriatric diseases, multi-morbidity coexistence management	Pregnancy risk stratification, labor prediction
Intervention mechanism	Fall detection, first aid notification, family linkage	Emergency obstetric warning, hospital referral coordination
Content services	Elderly health information, chronic disease management guidance	Pregnancy nutrition, postpartum recovery guidance

Nay AI model and version evolution

Nay AI has not officially released a versioned product, and the public information does not include a verifiable version number or official release mark. The following is a summary of the timeline and technical components disclosed on the official website.

Technology precursor stage (before 2020): The founding team developed the URUS integration architecture and Skimmer natural language understanding engine in the field of education technology, and some components were used in educational software products. This experience laid the foundation for the underlying technology stack of the subsequent medical and health platform.

Direction Transformation Period (2020-2023): The COVID-19 epidemic prompted the founding team to shift their technology accumulation to the medical and health field. Official website description: "The cruel consequences of COVID-19 have made us realize that these technologies can make more profound contributions to mankind if applied to the medical and health field." Starting in 2023, the brand and infrastructure of the Nay.AI platform will be built.

Brand Building Period (2023-2026): From July 2023 to May 2024, the official website blog will continue to publish medical and health news content to establish the brand's content authority in the medical and health field. The investor page, nursing service page (Care), and team introduction page are gradually launched online. As of now, the core functions of the platform are not open to the public.

Current status: The official website shows that the platform is still in the development stage and "has yet to formally launch". The public version_number (1.2.0, 1.0.0) is placeholder information, which is subject to the actual official released version. Key milestones worthy of attention in the future include: the launch of beta testing, the release of the first official version, and the access of the first cooperative medical institution.

Nay AI’s technical advantages

Nay AI's technical route emphasizes "using existing mature AI technology to solve specific medical scenario problems" rather than pursuing the ultimate scale of model parameters.

URUS Integrated Architecture: This is the underlying infrastructure core of Nay AI. URUS is designed as a cross-system data integration middleware that can unify multi-source heterogeneous data from wearable devices, medical institution information systems (HIS/EMR), pharmacy databases, health content platforms, etc. into a standardized format. In medical scenarios, data silos are the biggest efficiency bottleneck, and URUS's role is to break this bottleneck. Technical Implications: The value of an integrated architecture depends entirely on the number of connectors adapted and the degree of standardization, and the initial phase may only cover mainstream devices and systems.

Skimmer Natural Language Understanding Engine: An NLU engine optimized for medical text, responsible for extracting key semantic information from unstructured medical records, health information, and doctor-patient conversations. Compared with the general NLU model, Skimmer has made special optimizations in medical term recognition, symptom-disease relationship extraction, and medication information structuring. Applicable Boundary: Medical NLU has much higher accuracy requirements than general scenarios - an incorrect symptom identification may lead to serious clinical consequences. Therefore, Skimmer needs to undergo sufficient medical corpus training and clinical verification before actual deployment.

Computer vision capabilities: Subhashis, a core member of the team, is a computer vision professor at IIT Delhi, which means that Nay AI has academic advantages in medical image analysis (such as automatic interpretation of X-ray CT scans). However, there is a significant distance between academic capabilities and productization. Medical imaging AI products require regulatory approvals such as FDA/CE, and the time cycle is usually 2-5 years.

Edge Computing and 5G: For remote monitoring scenarios, the platform adopts an edge computing architecture to complete data processing close to the data source, reducing the delay and bandwidth cost of transmission to the cloud. The high-bandwidth and low-latency characteristics of 5G networks support real-time video consultations and high-frequency sensor data streams. Implementation Challenge: Edge computing relies on hardware devices deployed in users’ homes. The cost, installation and maintenance of the equipment, and user acceptance are key variables in actual promotion.

Comparison with traditional AI medical platforms:

Dimensions	Nay AI	Babylon Health	Ada Health
Core Objectives	Elder Care + Maternity Care	Teleconsultation + Primary Care	Symptom Assessment + Health Guidance
AI capabilities	URUS + Skimmer + CV	NLP symptom matching	Knowledge graph + probabilistic reasoning
Deployment method	Edge computing + cloud	Cloud-based	Mobile + cloud
Product stage	Not released	Large-scale operation	Large-scale operation
Regulatory certification	To be obtained	Already	Already
Open Source Policy	Undisclosed	Closed Source	Closed Source

How to use Nay AI

Nay AI has not yet opened its core functions to the public. Currently, only information display and content browsing on the official website are available.

Currently available entrances:

• Official website information browsing (https://nay.ai/): Visit the official website to learn about the project vision, team background, technical roadmap and investor information. The homepage of the website provides a notice of the "login" entrance, saying that "the login function will be enabled soon, and you can use your LinkedIn account to log in to access more platform content."
• Medical and Health News Aggregation: The official website news section (Healthcare News) and blog section (Blog) aggregate a large amount of medical and health-related content, covering topics such as the application of AI in medical care for the elderly and pregnancy health. This part of the content can be used as an information reference to understand the areas of focus of the platform.
• Investor Contact: The official website has set up an investor page, and interested investment institutions can contact the team through the page channel.

Estimated future usage path: According to the official website description, after the official release, users will log in through their LinkedIn account to obtain personalized health monitoring AI-assisted decision-making and telemedicine services. The nursing service page (Care) hints that the platform may provide direct manual nursing service appointment and coordination functions in the future. The product documentation after official release shall prevail.

Product Pricing for Nay AI

As of now, Nay AI has not disclosed any level of product pricing information.

C client/individual users: The official website emphasizes "affordable healthcare" but does not give a specific price range. For the two target groups of elderly users and pregnant women, pricing strategies may need to consider complex factors such as social security coverage, medical insurance payment and self-pay ratio. Follow-up concerns: whether there is a free level of health content access, whether basic health monitoring requires a subscription, and whether advanced AI analysis is charged separately.

B-side/institutional cooperation: The pricing for cooperation with nursing homes, hospitals, and insurance companies has not been disclosed. B2B pricing in healthcare typically includes a platform license fee, implementation services fee, and variable fees per user/unit monitored. For specific details, please refer to the official commercial terms and conditions.

Implicit cost prediction: For elderly users, in addition to platform subscription fees, the purchase cost of edge computing hardware devices (such as health monitoring sensors, wearable devices) and home network conditions are necessary pre-investments for actual use. For institutional customers, the time cost of system integration, staff training and compliance audits can be much higher than the software licensing fee itself.

Nay AI application scenarios

Nay AI’s scenario design revolves around the two core areas of elderly care and maternal care. The following three types of scenarios have been clearly described in its public documents:

• Home security monitoring for independent elderly people: Elderly people living alone can access smart health monitoring devices through the Nay AI platform to monitor daily activity patterns, medication compliance and basic vital signs in real time. When an abnormality is detected (such as long periods of inactivity, falls, abnormal body temperature), the system automatically notifies preset family members or emergency services. Differences from traditional solutions: Traditional elderly care monitoring relies on manual inspections or fixed cameras. Nay AI attempts to use edge computing to achieve more proactive risk warnings instead of passive post-event responses. Key points of verification: Sensitivity and specificity of fall detection, false alarm rate control, and notification delay time.
• Chronic disease comorbidity management for the elderly: For elderly patients suffering from multiple chronic diseases (such as hypertension, diabetes, heart disease), the platform AI integrates diagnostic recommendations and medication plans from different specialties, identifies potential drug interaction risks, and generates an integrated health management plan. Engineering Implications: Multi-disease co-management is one of the most complex scenarios in medical AI and requires high-quality cross-department data integration and medical knowledge graph support. Nay AI’s Skimmer NLU engine takes on the core inference role in this scenario.
• Remote management of high-risk pregnant women: Provide remote monitoring and intelligent early warning services for pregnant women at risk of pregnancy complications. The platform tracks key pregnancy indicators (blood pressure, blood sugar, weight, fetal movement), and the AI ​​model predicts the probability of complications based on historical data, automatically recommending medical treatment or contacting an obstetrician when the threshold is reached. Clinical basis: Sudeshna, a core member of the team, as a senior obstetrician and expert in robotic surgery, provided clinical professional endorsement for this scenario.
• Backend decision support for medical institutions: Provide AI-assisted diagnosis suggestions, treatment plan recommendations and patient risk assessments for geriatric departments or primary health centers

estimate. The implementation of this scenario relies on integration with existing HIS/EMR systems and the cultivation of medical staff's trust in AI-assisted tools.

Prerequisites for scenario implementation: The implementation of all the above scenarios relies on one core premise - the platform is officially released and the cooperation and docking with medical institutions and hardware equipment manufacturers is completed. At this stage, these scenarios should be considered "technical design solutions" rather than "available services".

Applicable groups of Nay AI

The target user group of Nay AI covers direct beneficiaries and indirect participants, but its current incompatibility boundaries need to be clarified:

• Children and caregivers of the elderly: For the children of the elderly living alone at home, Nay AI provides remote monitoring and risk warning capabilities, which can shift from passively waiting for notifications to actively controlling the health status of their parents. Unsuitable Boundary: If the elderly refuse to use wearable devices or do not have basic network usage capabilities, the actual monitoring coverage of the platform will decrease significantly. For this population, device acceptance and ease of operation are more important than AI capabilities themselves.
• Older group (over 60 years old and with certain digital literacy): the core direct users of the platform. Suitable for elderly people who are aware of active health management and are able or willing to learn to use smart devices. Unfit Boundary: For elderly people who are obviously resistant to digital technology or have declining cognitive abilities, the interaction threshold of the platform may be too high. In such a scenario, manual care services (such as what the official Care page implies) may be a more practical solution.
• Pregnant women (especially high-risk pregnancy groups): the second largest core user group of the platform. AI-driven remote monitoring and risk warnings have real value in reducing unnecessary prenatal visits while not missing key risk signals. Prerequisites: Requires the participation and cooperation of obstetricians. AI warnings need to be connected with clinical pathways to be effective, rather than relying solely on APP push notifications.
• Medical Institutions and Nursing Homes: As B-side customers, embed Nay AI’s capabilities into existing geriatrics, rehabilitation centers and nursing home service systems. Purchasing Prerequisites: Institutions need to have basic digital infrastructure (HIS/EMR system, network coverage) and be willing to integrate AI-assisted tools into daily diagnosis and treatment processes. For primary medical units that have not yet completed their informatization foundation, the direct deployment of Nay AI has limited value.
• Investment Institutions and Social Impact Funds: Focus on medical AI and

For investors in the aging track, Nay AI’s ESG attributes (aligned with the United Nations’ 10-Year Plan for Healthy Aging) and the huge demand in the elderly care market constitute investment attractions. Key points for verification before investment: Regulatory approval path (HIPAA, ICP, FDA/CE, etc.), clinical verification planning, and differentiated positioning of competitive products.

Summary of non-applicable groups: The current positioning of Nay AI is completely unsuitable for users who need to use a mature AI medical platform immediately; it is not suitable for non-English speaking areas (current content is mainly in English); it is not suitable for healthy young people who do not have chronic disease management needs - its functional design is overly focused on elderly care and maternity care, and has limited general health management value for young healthy groups.

Summary and Outlook of Nay AI

The core competitiveness of Nay AI lies in its special starting point of "transforming medical health from a technological predecessor" - the URUS integrated architecture and Skimmer NLU engine have been accumulated through years of actual development and are not technical ideas starting from scratch. The founding team spans multi-dimensional backgrounds in academia, clinical, entrepreneurship and investment, and also provides differentiated industry perspectives for product definition.

Current core advantages: The technical infrastructure has many years of accumulation; the team is complementary in computer vision (Subhashis), clinical medicine (Sudeshna) and commercialization (Avijit, Nitin); product positioning accurately cuts into the two fast-growing medical market segments of aging society and maternal health; the connection with the United Nations Ten-Year Plan for Healthy Aging provides positive value at the brand and ESG levels.

Current major limitations and risks: The platform has not been officially released, and all functional features are in the design stage, and there is the possibility of delivery delays or reduced functionality; the regulatory approval cycle (HIPAA, FDA/CE, etc.) faced by medical AI products usually takes 2-5 years, which means Nay AI It will be difficult to enter the mainstream medical market in the United States or the European Union in the foreseeable future; the project was launched in India but the office location and complete company registration information were not disclosed in a prominent position on the front end, posing an obstacle to the due diligence of corporate customers and investors; the official website content is mainly news aggregation, with limited display of core technical details and insufficient verifiability of the technical route; the clinical verification of the AI medical platform requires the completion of randomized controlled trials on real-world data, which is a long process that costs tens of millions of dollars and has uncertain results; competing products (such as Babylon Health, Ada Health, K Health) has entered the stage of scale and compliance operations. As a latecomer, Nay AI needs to find a breakthrough point in differentiated positioning and capital efficiency.

Key nodes for subsequent observation:

1. Beta test launch: The access of the first real user group is the first substantive test of the platform’s basic capabilities.
2. Regulatory certification progress: Whether a HIPAA or equivalent compliance audit has been initiated is a sign of whether a project takes medical product compliance seriously.
3. The first institutional partner: The ability to reach cooperation with a reputable hospital or nursing home is a key turning point for the platform from concept to implementation.
4. Financing rounds and amounts: The scale of the next round of financing and investor background can be used as an important reference for judging project progress and capital recognition.

Procurement/Adoption Risk Assessment: For individual users, it is not recommended to connect any personal health data to Nay AI until the platform is officially released and passes the security audit. For medical institutions and investors, it is recommended that Nay AI be regarded as an "early-stage proof-of-concept project" rather than a "mature product" - it is not suitable to make substantial purchase or investment commitments until beta testing is completed, regulatory certification is initiated, and at least one reference customer is implemented. Compared with the time to market and compliance progress of similar competing products, the main value of Nay AI at the current stage lies in focusing on its technical roadmap and team execution rather than immediate adoption.

Related tools: perplexity, you-com

Version Info

• Nay AI 2025 ：Added intelligent classification and trend analysis functions for industry reports to enhance connection capabilities with business data sources. （~2025-03）
• Nay AI Launch ：The initial version focuses on semantic search for business news and industry reports. （~2024-05）